2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
Manufacturer Commercial Supple Remdesivir et intermedia cum High Quality
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl((S)-(perfluorophenoxys)(phosphoryl)-L-alaninatum CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy) phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolitae (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermedia CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Nomen chemicum | 2,3,5-Tri-O-benzyl-D-ribonolactone |
Synonyma | 2,3,5-Tri-O-Benzyl-D-Ribono-1,4-Lactone;Remdesivir medium |
CAS Number | 55094-52-5 |
CATTUS Number | RF-PI301 |
Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
Formulae hypotheticae | C26H26O5 |
M. Pondus | 418.49 |
Liquescens punctum | 54.0-55.0℃ |
Repono Condition | Locus temperatus |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Flavo vel albo solidus |
Solubilitas | Solutum in CH2Cl2 et insolubile in H2O |
NMR et Ms | Si parere |
Lepidium sativum | IR et TLC |
umor | ≤1.0% |
Residere in Ignition | ≤0.50% |
Omnis immunditia | ≤0.50% |
Metalla gravis | ≤50ppm |
HPLC (210nm) | ≥99.0% |
HPLC (ELSD) | ≥99.0% |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedia Remdesiviri (CAS 1809249-37-3) |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
2.3,5-Tri-O-benzyl-D-ribonolactone (CAS 55094-52-5) est Remdesivir medium.Remdesivir (CAS 1809249-37-3) est medicamentum novum antivirale in genere analogorum nucleotidis, adhibitum in curatione COVID-19.Remdesivir (GS-5734) nova est analogi nuclei antiviralis quae vetat virus hepatitis murinum (MHV) cum similibus EC50 sicut SARS-CoV et MERS-CoV.Coronavirus (CoVs) sunt sensus positive, RNA virus solitarii qui amplis exercitibus animalium inficiunt.In hominibus, CoVs tamquam frigora et pneumonia typice causantes agnita sunt usquedum ad emergentem gravium respiratorii acuta syndrome coronavirus (SARS-CoV) in Medio Oriente 2002 et syndrome respiratorii coronavirus (MERS-CoV) in MMXII e fontibus zoonoticis.Remdesivir monophosphoramidata prodrug C-adenosini nucleosidi analogi GS-441524 est.In tumore cerebri morato (DBT) cellulis MHV, GS-5734 infectis potentius inhibuit MHV quam GS-441524, cum GS-5734 EC50 de 0.03 M. Praeterea valores EC50 post curationem cum GS-441524 et GS-5734 determinati sunt. in SARS-CoV- et MERS-CoV pestilentiae culturas primas humanas airway epithelial (HAE) .